Canada Life’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,623
| Closed | -$13K | – | 2518 |
|
|
2021
Q3 | $13K | Hold |
2,623
| – | – | ﹤0.01% | 2486 |
|
|
2021
Q2 | $17K | Hold |
2,623
| – | – | ﹤0.01% | 2507 |
|
|
2021
Q1 | $20K | Hold |
2,623
| – | – | ﹤0.01% | 2505 |
|
|
2020
Q4 | $17K | Hold |
2,623
| – | – | ﹤0.01% | 2560 |
|
|
2020
Q3 | $17K | Hold |
2,623
| – | – | ﹤0.01% | 2469 |
|
|
2020
Q2 | $22K | Hold |
2,623
| – | – | ﹤0.01% | 2476 |
|
|
2020
Q1 | $20K | Hold |
2,623
| – | – | ﹤0.01% | 2371 |
|
|
2019
Q4 | $22K | Buy |
+2,623
| New | +$22K | ﹤0.01% | 2476 |
|
|
2019
Q3 | – | Sell |
-4,943
| Closed | -$55K | – | 1393 |
|
|
2019
Q2 | $55K | Hold |
4,943
| – | – | ﹤0.01% | 2414 |
|
|
2019
Q1 | $53K | Hold |
4,943
| – | – | ﹤0.01% | 2243 |
|
|
2018
Q4 | $72K | Hold |
4,943
| – | – | ﹤0.01% | 2251 |
|
|
2018
Q3 | $91K | Hold |
4,943
| – | – | ﹤0.01% | 2222 |
|
|
2018
Q2 | $113K | Buy |
4,943
+3,143
| +175% | +$71.9K | ﹤0.01% | 2147 |
|
|
2018
Q1 | $51K | Hold |
1,800
| – | – | ﹤0.01% | 2362 |
|
|
2017
Q4 | $38K | Hold |
1,800
| – | – | ﹤0.01% | 2421 |
|
|
2017
Q3 | $32K | Hold |
1,800
| – | – | ﹤0.01% | 2424 |
|
|
2017
Q2 | $28K | Hold |
1,800
| – | – | ﹤0.01% | 2450 |
|
|
2017
Q1 | $31K | Hold |
1,800
| – | – | ﹤0.01% | 2401 |
|
|
2016
Q4 | $20K | Hold |
1,800
| – | – | ﹤0.01% | 2491 |
|
|
2016
Q3 | $28K | Hold |
1,800
| – | – | ﹤0.01% | 2435 |
|
|
2016
Q2 | $18K | Buy |
+1,800
| New | +$18K | ﹤0.01% | 2473 |
|